Safety and Efficacy Study of Iontophoretic Dexamethasone Phosphate Ophthalmic Solution to Treat Non-Infectious Anterior Segment Uveitis

NCT01505088 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

193

Enrollment

INDUSTRY

Sponsor class

Conditions

Anterior Uveitis

Interventions

DRUG: 40 mg/mL Dexamethasone phosphate ophthalmic solution
DRUG: Prednisolone Acetate (1%) Eyedrops
DRUG: 100 mM sodium citrate buffer solution
DRUG: Placebo Eyedrops

Sponsor

Eyegate Pharmaceuticals, Inc.